Litcius/Paper detail

Uptake of biosimilars for TNF-α inhibitors adalimumab and etanercept following the best-value biological medicine initiative in Ireland

Brittany M. Duggan, Amelia Smith, Michael Barry

2021International Journal of Clinical Pharmacy25 citationsDOI

Topics & Concepts

BiosimilarAdalimumabMedicineEtanerceptPharmacyInfliximabAlternative medicineHealth careNocebo EffectValue (mathematics)Family medicineInternal medicineEconomic growthDiseaseMachine learningEconomicsPlaceboRheumatoid arthritisPathologyComputer scienceBiosimilars and Bioanalytical MethodsHealth Systems, Economic Evaluations, Quality of LifePharmaceutical studies and practices
Uptake of biosimilars for TNF-α inhibitors adalimumab and etanercept following the best-value biological medicine initiative in Ireland | Litcius